机构:[1]Beijing Union Med Coll Hosp, Dept Hematol, Beijing, Peoples R China[2]Fu Xing Hosp Affiliated Capital Med Coll, Beijing, Peoples R China[3]Capital Med Univ, Xuan Wu Hosp, Beijing, Peoples R China首都医科大学宣武医院[4]Xuanwu Hosp Affiliated Capital Med Coll, Beijing, Peoples R China首都医科大学宣武医院[5]Chinese Peoples Liberat Army, Mil Hosp 309, Beijing, Peoples R China[6]Capital Med Univ, Beijing Friendship Hosp, Dept Hematol, Beijing, Peoples R China首都医科大学附属北京友谊医院[7]Beijing Chao Yang Hosp, Beijing, Peoples R China北京朝阳医院[8]Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Beijing, Peoples R China[9]Beijing Chuiyangliu Hosp, Beijing, Peoples R China[10]Beijing Tsinghua Changgung Hosp, Beijing, Peoples R China[11]Beijing Hosp, Beijing, Peoples R China[12]Beijing Tongren Hosp, Beijing, Peoples R China首都医科大学附属北京同仁医院首都医科大学附属同仁医院[13]Chinese Peoples Liberat Army Rocket Army Hosp, Beijing, Peoples R China[14]PLA Army Gen Hosp, Beijing, Peoples R China[15]Peking Univ, Aerosp Ctr Hosp, Dept Hematol, Beijing, Peoples R China
第一作者机构:[1]Beijing Union Med Coll Hosp, Dept Hematol, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Li Hongmin,Wang Liru,Wu Yue,et al.Very Low-Dose Decitabine Is Effective in Treating Intermediate or High Risk Myelodysplastic Syndrome[J].BLOOD.2016,128(22):doi:10.1182/blood.V128.22.5536.5536.
APA:
Li, Hongmin,Wang, Liru,Wu, Yue,Su, Li,Zhao, Hong...&Han, Bing.(2016).Very Low-Dose Decitabine Is Effective in Treating Intermediate or High Risk Myelodysplastic Syndrome.BLOOD,128,(22)
MLA:
Li, Hongmin,et al."Very Low-Dose Decitabine Is Effective in Treating Intermediate or High Risk Myelodysplastic Syndrome".BLOOD 128..22(2016)